Literature DB >> 1833517

Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3-hour) postexercise images.

R Taillefer1, M Primeau, P Costi, R Lambert, J Léveillé, Y Latour.   

Abstract

Technetium-99m-sestamibi, a new myocardial perfusion imaging agent, does not show significant or rapid myocardial redistribution following its intravenous injection at stress. The purpose of this study was to evaluate the myocardial clearance of 99mTc-sestamibi and ischemic/normal wall ratios at 1 hr and at 3 hr after injection at stress in patients with significant coronary artery disease. Twenty-five patients with ischemic defects on 201Tl scans (n = 15) and/or significant disease on coronary angiogram (n = 18) were prospectively studied. Planar images were obtained at 65 and at 190 min after an injection at stress of 20-25 mCi of 99mTc-sestamibi. A rest study was performed 1-6 days later. Ischemic/normal wall ratios were 0.73 +/- 0.10 and 0.83 +/- 0.12 (p less than 0.05) at 1 and 3 hr, respectively (0.98 +/- 0.15 at rest). Myocardial washout was 26% +/- 12% for normal walls and 15% +/- 8% for ischemic walls (p less than 0.001). Segmental analysis showed 48 and 46 ischemic segments at 1 and 3 hr, respectively. In conclusion, although only a few ischemic segments were missed at 3 hr, significantly lower ischemic/normal wall ratios were found at 1 hr. Faster myocardial washout from normal walls is responsible for the partial reduction of this ratio.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833517

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  28 in total

Review 1.  An overview of radiotracers in nuclear cardiology.

Authors:  W Acampa; C Di Benedetto; A Cuocolo
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

Review 2.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

3.  Measuring myocardium at risk in acute myocardial infarction--a continuing challenge.

Authors:  Todd D Miller; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

4.  New reconstruction algorithm allows shortened acquisition time for myocardial perfusion SPECT.

Authors:  Ines Valenta; Valerie Treyer; Lars Husmann; Oliver Gaemperli; Michael J Schindler; Bernhard A Herzog; Patrick Veit-Heibach; Ronny R Buechel; René Nkoulou; Aju P Pazhenkottil; Philipp A Kaufmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-18       Impact factor: 9.236

5.  Washout and redistribution between immediate and two-hour myocardial images using technetium-99m sestamibi.

Authors:  W S Richter; M Cordes; D Calder; H Eichstaedt; R Felix
Journal:  Eur J Nucl Med       Date:  1995-01

6.  Furifosmin: the road to the final four.

Authors:  A S Iskandrian
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

Review 7.  Choosing a thallium-201 or technetium 99m sestamibi imaging protocol.

Authors:  J E Udelson
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

Review 8.  The maze of myocardial perfusion imaging protocols in 1994.

Authors:  F J Wackers
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

9.  A method of simultaneous dual-radionuclide cardiac imaging with technetium 99m and thallium 201. I: Analysis of interradionuclide crossover and validation in phantoms.

Authors:  H Weinstein; M A King; C P Reinhardt; B A McSherry; J A Leppo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

10.  Detection of coronary artery disease: comparison between technetium 99m-labeled sestamibi single-photon emission computed tomography and two-dimensional echocardiography with dipyridamole low-level exercise-stress.

Authors:  M J Cramer; E E van der Wall; W Jaarsma; J F Verzijlbergen; M G Niemeyer; A H Zwinderman; E K Pauwels
Journal:  J Nucl Cardiol       Date:  1996 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.